AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Mark Leuchtenberger named president and CEO.(Therion Biologics Corp.)(Brief Article)
2002 MAY 15 - (NewsRx.com & NewsRx.net) -- Therion Biologics Corp., a leader in the development of therapeutic cancer vaccines, announced the appointment of Mark Leuchtenberger as the company's new president and CEO.
Leuchtenberger joins Therion with extensive experience in biopharmaceutical marketing, product commercialization, and business development. During his 11 year career at Biogen, he managed the North American launch of Avonex and led the company's successful efforts to secure U.S. and European market leadership in the multiple sclerosis field.
Dennis L. Panicali, who founded Therion Biologics and has served as president and CEO for the last 11 years, will continue to ...
- Targanta Appoints Mark Leuchtenberger, Former President and CEO of Therion...
- Press release article from: PR Newswire September 18, 2006 700+ words
...announced today the appointment of Mark Leuchtenberger as the company's new President...Leuchtenberger joins Targanta from Therion Biologics, where he was formerly President...Leuchtenberger's leadership at Therion Biologics, the company filed its first IND...
- Therion Names Mark Leuchtenberger, Former Vice President of Biogen...
- Press release article from: PR Newswire March 27, 2002 700+ words
...Mass. -- Therion Biologics Corporation...appointment of Mark Leuchtenberger as the company...Contacts: Mark Leuchtenberger or Dennis L...Ph.D. Therion Biologics Corporation...11690X86441534 Contact: Mark Leuchtenberger or Dennis L...D., of Therion ...
- Therion Biologics to Present at Mass Opportunities Biotechnology Investment...
- Press release article from: PR Newswire October 29, 2004 700+ words
...Oct. 29 /PRNewswire/ -- Therion Biologics Corporation today announced that Mark Leuchtenberger, President and CEO of Therion...11:10 a.m. ET. About Therion Biologics Corporation Therion Biologics Corporation develops therapeutic...
- Therion Biologics and the National Institute of Allergy and Infectious...
- Press release article from: PR Newswire December 19, 2002 700+ words
...commented Mark Leuchtenberger, President...Officer of Therion Biologics. "This...Massachusetts. Mark Leuchtenberger President and CEO Therion Biologics Corporation...CONTACT: Mark Leuchtenberger, President and CEO of Therion Biologics Cor
- Therion Biologics Corporation Secures $39 Million in Private Equity Financing...
- Press release article from: PR Newswire September 8, 2003 700+ words
...said Mark Leuchtenberger, President...Officer of Therion Biologics Corporation...Contacts: Mark Leuchtenberger President and CEO Therion Biologics Corporation...CONTACT: Mark Leuchtenberger, President and CEO of Therion Biologics ...
- Therion Biologics Licenses ICAM-1 from Boehringer Ingelheim.
- Press release article from: PR Newswire September 17, 2002 700+ words
...said Mark Leuchtenberger, President...Officer of Therion Biologics. "TRICOM...Contacts: Mark Leuchtenberger President and CEO Therion Biologics Corporation...CONTACT: Mark Leuchtenberger, President and CEO of Therion Biologics Corporation...
- Therion Biologics Obtains Rights to Biogen Idec LFA-3 Patents.
- Press release article from: PR Newswire December 15, 2003 700+ words
...said Mark Leuchtenberger, President...Officer of Therion Biologics. "Therion...Contacts: Mark Leuchtenberger President and CEO Therion Biologics Corporation...CONTACT: Mark Leuchtenberger, President and CEO of Therion Biologics Corporation...
- Therion Biologics Corporation Appoints Thomas J. Schuetz, M.D., Ph.D., as Chief...
- Press release article from: PR Newswire June 30, 2003 700+ words
...Massachusetts. Contacts: Mark Leuchtenberger President and CEO Therion Biologics Corporation (617) 475-7500...617) 577-8110 CONTACT: Mark Leuchtenberger, President and CEO of Therion Biologics Corporation, +1-617-475...
Source: HighBeam Research, Mark Leuchtenberger named president and CEO.(Therion Biologics...